Navigation Links
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
Date:10/29/2008

m regular human insulin by its rapid onset and shorter duration of action. When used as a mealtime insulin, Apidra(R) should be given within 15 minutes before or within 20 minutes after starting a meal. Due to the short duration of action of Apidra(R), patients also require a longer-acting insulin or insulin infusion pump therapy. Any change of insulin should be made cautiously and only under medical supervision. Tell your doctor about all other medicines and supplements you are taking. Glucose monitoring is recommended for all patients with diabetes.

Possible side effects may include low blood sugar; injection site reactions, such as changes in fat tissue at the injection site; and allergic reactions, such as itching and rash. Less common, but potentially more serious or life-threatening, is generalized allergy to insulin, including anaphylactic reactions.

When used in a pump, do not mix Apidra(R) with any other insulin or liquid. If the pump or infusion set does not work right, you may not receive the right amount of insulin. Hypoglycemia, hyperglycemia, or ketosis can happen. Problems should be identified and corrected as quickly as possible.

For full prescribing information, please visit http://www.Apidra.com.

IMPORTANT SAFETY INFORMATION FOR LANTUS(R)

Prescription Lantus(R) is for adults with type 2 diabetes or adults and children (6 years and older) with type 1 diabetes who require long-acting insulin for the control of high blood sugar.

DO NOT DILUTE OR MIX LANTUS(R) WITH ANY OTHER INSULIN OR SOLUTION. It will not work as intended, and you may lose blood sugar control, which could be serious. Do not change your insulin without talking with your doctor. The syringe must not contain any other medication or residue. You should not use Lantus(R) if you are allergic to insulin. Lantus(R) is a long-acting insulin you inject just once a day, at the same time each day. You mus
'/>"/>

SOURCE Sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 18, 2014  Sanguine Biosciences – a biotechnology ... study recruitment – will use its proprietary mobile ... Pfizer Inc. find and recruit people diagnosed with ... members to participate in voluntary research, which will ... and hopefully aid in informing the development of ...
(Date:11/18/2014)... 2014 BioLink 2015, the BioPh & ... co-organized by CCCMHPIE ( China Chamber of ... Health Products), UBM Live and Beijing Yizhuang Biomedical ... at Beijing Yizhuang Biomedical Park.   ... This event will gather 200+ decision makers from biopharmaceutical ...
(Date:11/18/2014)... , Nov. 17, 2014  Nopras Technologies ( ... Stewart B. Rosenberg to the position of ... Rosenberg joins Nopras from Bio-Investigations Ltd., a specialized ... he founded 27 years ago, focused in the ... With undergraduate and graduate degrees in biology, biochemistry, ...
Breaking Medicine Technology:Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 3Nopras Technologies Inc. Appoints Director Of Business Development - East Coast Operations 2Nopras Technologies Inc. Appoints Director Of Business Development - East Coast Operations 3
... Lupin Pharmaceuticals, Inc. (LPI) announced today that the ... for the Company,s Abbreviated New Drug Application (ANDA) to ... tablets.  Commercial shipment of the product has commenced. ... mg tablets are the AB-rated generic equivalent of Levaquin, ...
... Therapeutics (NYSE Amex: CXM ) today ... Nuclear Cardiology Core Laboratory (Cedars-Sinai Core Laboratory), Los ... lab for the Company’s Generx ASPIRE clinical study. ... consolidation and analysis of SPECT (single-photon emission computed ...
Cached Medicine Technology:Lupin Announces Launch of Generic Levaquin® Tablets 2Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 2Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 3Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 4Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 5Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 6Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 7
(Date:11/18/2014)... OpenWorks, one of America’s leading commercial cleaning franchises, ... Invitational. The John C. Lincoln Health Foundation holds the ... Mission community programs. Open Works was a Tee Sponsor ... at Camelback Golf Club in Scottsdale. More than 250 ... Mission — including a food bank, children's dental clinic, ...
(Date:11/18/2014)... 2014 As children head back to ... look at fall as the perfect time to refresh ... , Orange County facial plastic surgeon, has observed a ... At the Gallery of Cosmetic Surgery he has noticed ... non-invasive cosmetic surgery procedures. , “Non-invasive cosmetic treatments ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... people on the verge of burning out are more likely ... suffering from so-called vital exhaustion -- a toxic combination of ... risk of developing heart disease, researchers report. "In our ... And I think, when that stress is left unchecked for ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 A Diet ... of patients throughout the country are turning back the ... ever before. This is because the company has recently ... their already impressive collection of prescription and non-prescription diet ... have incorporated Diet Doc’s best anti-aging human ...
(Date:11/17/2014)... 2014 HIPAA Secure Now! was voted ... members of the ASCII Group, a membership-based community of ... handed out at this year’s ASCII Success Summit, recognizing ... to helping their peers grow successful businesses. Winners in ... at the Summit on October 23, 2014 in Atlantic ...
Breaking Medicine News(10 mins):Health News:OpenWorks Sponsors 2014 Lincoln Guild Invitational Golf Tournament Hosted by Scottsdale's Camelback Golf Club 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3Health News:The ASCII Group Names HIPAA Secure Now! Esteemed Noble Partner at ASCII Success Summit 2014 2Health News:The ASCII Group Names HIPAA Secure Now! Esteemed Noble Partner at ASCII Success Summit 2014 3
... TUESDAY, July 27 (HealthDay News) -- Taking advantage of recent ... breast cancer, European scientists have analyzed those variants in relation ... with certain variants and for certain tumor types. In ... the most use to scientists in their effort to understand ...
... (July 28, 2010) Errors in diagnosis place a ... system and can be devastating for affected patients. ... of comprehensive and coordinated primary care could potentially address ... researchers from Baylor College of Medicine ( www.bcm.edu ) ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, July ... early run the risk of developing breathing problems compared with ... -- defined as between the 34th and 37th weeks of ... born in the United States, the researchers said. And too ...
... clinical trial offering vascular-targeted photodynamic therapy to patients with ... uses a light-activated drug to deliver light energy waves ... prostate cancer cells. "This minimally invasive ... destroy the cancer without making any incision or causing ...
... the most common childhood psychiatric condition in the ... school on time than students with other mental-health disorders ... study by researchers at the UC Davis School of ... third of students with ADHD, twice the proportion as ...
... quicker and more efficient at implementing surgical safety initiatives ... providing a standard of surgical care that is at ... of care services, according to an 18-month series of ... Department of Surgery. "The quality and standard of ...
Cached Medicine News:Health News:Genetic Risk Score Can Predict Odds For Breast Cancer 2Health News:Reform of primary care could reduce diagnostic errors 2Health News:Reform of primary care could reduce diagnostic errors 3Health News:Reform of primary care could reduce diagnostic errors 4Health News:Delivering Babies Even a Few Weeks Early Ups Respiratory Risks 2Health News:Delivering Babies Even a Few Weeks Early Ups Respiratory Risks 3Health News:NYU Langone offers vascular-targeted photodynamic therapy for localized prostate cancer 2Health News:ADHD, conduct disorder and smoking most strongly related to dropping out of high school 2Health News:ADHD, conduct disorder and smoking most strongly related to dropping out of high school 3Health News:ADHD, conduct disorder and smoking most strongly related to dropping out of high school 4Health News:Smaller hospitals can provide safe and high-quality surgical care comparable to larger counterparts 2Health News:Smaller hospitals can provide safe and high-quality surgical care comparable to larger counterparts 3
Inquire...
Protects skin from corrosive drainage with the standard wear, FlexWear skin barrier. Security and confidence assured with porous tape, internal non-reflux valves, convenient drain valve....
FlexWear is a cross-linked hydrocolloid skin barrier that provides aggressive adherence and is designed for more than one day weartime....
Convenience, Protection, Comfort and Security -- FirstChoice pouches are your product of choice if you are looking for the convenience of a one-piece pouch that is either cut-to-fit or pre-cut to you...
Medicine Products: